9NL-27465-34451
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 222 / VA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
- 2020-12-31
- 2021-01-01
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Eye pain, Headache — Feeling: Good · HeadacheFree text: Pain with extraocular movements (calling this a Headache) for the past two mornings x 30 mins - 1 hourMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
- 2021-01-06
- 2021-01-13
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-28
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-21
- 2021-02-26
- 2021-03-05
- 2021-04-25
- 2021-07-23
- 2022-01-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Pain with extraocular movements (calling this a Headache) for the past two mornings x 30 mins - 1 hour
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release